Skip to content

Clinical trials

Mood Disorders trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mood Disorders Country / region: China Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20181
20211
20222
20231
20246
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting4
Unknown status3
Active, not recruiting2
Enrolling by invitation1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
First Affiliated Hospital of Zhejiang University3
Eli Lilly and Company2
Anhui Medical University1
Capital Medical University1
Fudan University1
Institute of Psychology, Chinese Academy of Sciences1
Islamic Azad University, Sanandaj1
Peking University1
Qilu Hospital of Shandong University1
Shanghai Mental Health Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mood Disorders16
Depressive Disorder4
Bipolar Disorder3
Major Depressive Disorder3
Mental Disorders3
Parkinson Disease2
Sleep Wake Disorders2
Alzheimer Disease1
Anxiety Disorders1
Attention Deficit Disorder with Hyperactivity1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.